FDA could use more appropriations, von Eschenbach tells Senate
This article was originally published in The Gray Sheet
Executive Summary
FDA could easily absorb an additional $100 million in funding over that proposed by the Bush Administration for fiscal 2009, but not the full $375 million increase recommended by the FDA Science Board in February, Commissioner Andrew von Eschenbach tells the Senate Appropriations Committee at an April 15 hearing. "I do believe we could absorb [$100 million] quite rapidly and ... effectively," but above that level "it would require greater stewardship to be sure we could implement those dollars as rapidly and effectively as we need to," he said. The administration's proposal provides a $51 million increase over 2008 in direct appropriations to FDA, bringing U.S. treasury funding of the agency to $1.77 billion (1"The Gray Sheet" March 3, 2008, p. 13)
You may also be interested in...
Funding Advice From FDA Science Board: Double Total Over Next Five Budgets
FDA Science Board members recommend a nearly $1.9 billion direct appropriation for the agency in fiscal 2009, a $375 million increase over 2008, and larger increases in each of the following five federal budgets
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.